Search research articles
Contact Us
Filters
Showing results (461-470 of 505) with videos related to
Page
of 51
Sort By:
Blood
|
September 26, 2013
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI
Edward A Copelan, Betty K Hamilton, Belinda Avalos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 22, 2014
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation
Edward A Copelan, Belinda R Avalos, Kwang Woo Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 14, 2018
Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation
Claudio G Brunstein, Marcelo C Pasquini, Soyoung Kim, et al.
Blood
|
July 24, 2024
A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy
Xiaoshuai Zhang, Bingcheng Liu, Jian Huang, et al.
Blood Advances
|
October 25, 2019
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia
Nelli Bejanyan, Soyoung Kim, Kyle M Hebert, et al.
Blood Advances
|
November 7, 2018
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia
Saurabh Chhabra, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2020
An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy
Yun Wang, Yan-Yu Cai, Tobias Herold, et al.
Cancer
|
June 18, 2016
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis
Abhinav Deol, Salyka Sengsayadeth, Kwang Woo Ahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2016
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
Brian C Shaffer, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Bone Marrow Transplantation
|
January 19, 2018
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT
David Buchbinder, Debra Lynch Kelly, Rafael F Duarte, et al.
Page
of 51
Search research articles
Search
Showing results (461-470 of 505) with videos related to
Sort By:
Page
of 51
Blood
|
September 26, 2013
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI
Edward A Copelan, Betty K Hamilton, Belinda Avalos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 22, 2014
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation
Edward A Copelan, Belinda R Avalos, Kwang Woo Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 14, 2018
Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation
Claudio G Brunstein, Marcelo C Pasquini, Soyoung Kim, et al.
Blood
|
July 24, 2024
A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy
Xiaoshuai Zhang, Bingcheng Liu, Jian Huang, et al.
Blood Advances
|
October 25, 2019
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia
Nelli Bejanyan, Soyoung Kim, Kyle M Hebert, et al.
Blood Advances
|
November 7, 2018
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia
Saurabh Chhabra, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2020
An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy
Yun Wang, Yan-Yu Cai, Tobias Herold, et al.
Cancer
|
June 18, 2016
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis
Abhinav Deol, Salyka Sengsayadeth, Kwang Woo Ahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2016
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
Brian C Shaffer, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Bone Marrow Transplantation
|
January 19, 2018
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT
David Buchbinder, Debra Lynch Kelly, Rafael F Duarte, et al.
Page
of 51